Masimo has launched its noninvasive hemoglobin monitor, which is part of the Masimo Rainbow SET. The device allows hemoglobin to be monitored in real time without the need to draw blood. According to results of a trial that had been released recently, the monitor helped to reduce blood transfusions in orthopedic surgery patients by 86%. In the trial, patients were either given the standard care procedure of blood draws or the continuous hemoglobin measurement as well as blood draws to aid in therapy. Only one patient from the Masimo group in the trial needed a blood transfusion while seven patients in the standard group received transfusions.
(Source Link: MedGadget)